Saline wash may offer safer way to treat lung infections
NCT ID NCT07666464
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This phase 3 trial tests whether early irrigation of the chest cavity with saline can improve outcomes for people with complicated pleural infections. 244 adults will receive either standard care or saline irrigation twice daily for three days. The goal is to see if this approach reduces death, the need for surgery, or additional enzyme therapy within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- saline (0.9% sodium chloride) irrigation
- What this could lead to
- If successful, this could offer a safer, simpler alternative to enzyme therapy for treating complicated pleural infections, reducing the need for surgery or additional treatments.
- What could go wrong
- This is a single trial with 244 participants, and earlier evidence is limited to one small study. The saline irrigation may not prove more effective than standard care, and there is a risk of adverse events like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
About 244 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Aug 2029
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults (≥18 years old) capable of fully understanding the study; * Complicated pleural infection (macroscopically purulent fluid, positive for bacteria on Gram's staining, positive on culture for bacterial infection, loculated effusion, pH \<7.2, great abundance) leading to thoracic drainage; * Initial ultrasound evaluation to estimate pleural fluid abundance and detect fibrinous septation; * Social security affiliation * Written informed consent * Highly effective contraceptive methods for women of childbearing age include: Combined hormonal contraception (estrogen and progestogen) associated with inhibition of ovulation (oral, intravaginal, transdermal); progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); intrauterine device; hormone- releasing intrauterine system; bilateral occlusion of the Fallopian tubes; vasectomized partner; sexual abstinence Exclusion Criteria: * Tuberculous pleural effusions; * Previous treatment with intrapleural fibrinolytic agents (urokinase, streptokinase, alteplase, or DNase) or intrapleural saline lavage; * Previous thoracic surgery for pleural infection; * Contraindications to auxiliary treatments, to fibrinolysis or surgery as well as to procedures such as drainage and lavage; * Pregnancy or lactation; * Expected survival of less than 3 months; * Thoracic drainage since more than 24h; * Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision); * Inability to give informed written consent; * Participation in another clinical trial; * Patient being a relative of the investigator or any member of the team directly involved in the study, including assistant physicians, pharmacists, nurses, and coordinators
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Pleural infections are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
CHU Amiens Picardie
RECRUITINGAmiens, Picardie, 80054, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Sleep hormone melatonin put to the test against lupus fatigue and inflammation
- Time-Restricted eating may ease lingering cancer fatigue
- Laughter therapy shows promise for menopause brain fog
- Keyhole surgery may beat standard care for chest infections
- Drama therapy boosts student Well-Being in small trial
- AI coach for therapists: could this improve mental health care?